CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Lisata Therapeutics agrees to Kuva Labs buyout at $4 per share

Neutral
AI Analysis

Summary

Lisata Therapeutics has agreed to be acquired by Kuva Labs at $4 per share in a buyout transaction.

Outcome Details

Lisata Therapeutics agreed to be acquired by Kuva Labs at $4 per share

Importance:7/10
Sentiment:
0.00
M&Aacquisitionbuyout
Related Companies

Read the original article

Published by yahoo_finance on June 10, 2026 1:36 PM

Read Original